Markets:

Overview

News

Currencies

International

Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

22.56 -1.61 (-6.66%)

Streaming Delayed Price Updated: 11:24 AM EDT, Jul 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19

November 29, 2021

From Immunome, Inc.

Via Business Wire

Immunome Reports Third Quarter 2021 Financial Results

November 15, 2021

From Immunome, Inc.

Via Business Wire

Immunome to Present at the Stifel Healthcare Conference

November 09, 2021

From Immunome, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion....

Via Benzinga

Why Immunome's Stock Is Soaring Today ↗

July 20, 2021

Immunome Inc (NASDAQ:IMNM) is surging Tuesday morning afte...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021 ↗

October 29, 2021

Upgrades For Preferred Bank (NASDAQ:

Via Benzinga

Immunome Announces Submission for Publication of Pre-clinical Research Detailing the Importance of Antibody Cocktail for SARS-CoV-2 Treatment and Prophylaxis

October 20, 2021

From Immunome, Inc.

Via Business Wire

64 Biggest Movers From Yesterday ↗

October 28, 2021

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...

Via Benzinga

Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 07, 2021

From Immunome, Inc.

Via Business Wire

54 Biggest Movers From Friday ↗

October 04, 2021

Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....

Via Benzinga

Immunome to Present Preclinical Data on Anti IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

September 30, 2021

From Immunome, Inc.

Via Business Wire

Immunome to Present at the Cantor Global Healthcare Conference

September 22, 2021

From Immunome, Inc.

Via Business Wire

Immunome to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

September 15, 2021

From Immunome, Inc.

Via Business Wire

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

45 Stocks Moving In Monday's Mid-Day Session ↗

September 13, 2021

Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...

Via Benzinga

Immunome's COVID-19 Antibody Neutralizes Two Variant Strains In Animal Studies ↗

September 07, 2021

Immunome Inc's (NASDAQ: IMNM) three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against SARS-CoV-2 Lambda (C.37) and Delta AY.1/2 (Delta...

Via Benzinga

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing

September 07, 2021

From Immunome, Inc.

Via Business Wire

72 Biggest Movers From Yesterday ↗

September 08, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Via Benzinga

Immunome Reports Second Quarter 2021 Financial Results

August 19, 2021

From Immunome, Inc.

Via Business Wire

38 Stocks Moving In Wednesday's Mid-Day Session ↗

July 21, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

July 21, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed...

Via Benzinga

62 Biggest Movers From Yesterday ↗

July 21, 2021

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher ↗

July 20, 2021

Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has...

Via Benzinga

Topics Stocks

Dow Rises 500 Points as Rally Gains Momentum ↗

July 20, 2021

Stocks are on a tear midday, as investors shake off delta variant fears and buy the dip in the wake of yesterday's selloff.

Via Talk Markets

Topics Stocks

34 Stocks Moving In Tuesday's Mid-Day Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA...

Via Benzinga

IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today ↗

July 20, 2021

IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results ↗

July 20, 2021

Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has...

Via Benzinga

Topics Stocks

Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant ↗

July 20, 2021

Immunome Inc (NASDAQ: IMNM) has announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against COVI-19 Delta variant...

Via Benzinga

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

July 20, 2021

From Immunome, Inc.

Via Business Wire

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.